L. Dirix

641 total citations
15 papers, 483 citations indexed

About

L. Dirix is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L. Dirix has authored 15 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L. Dirix's work include HER2/EGFR in Cancer Research (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). L. Dirix is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). L. Dirix collaborates with scholars based in Belgium, Germany and United Kingdom. L. Dirix's co-authors include Christoph Reinhardt, Martin Schüler, Christian Dittrich, Marcus Schmidt, M. E. Scheulen, Peter Obrist, Ahmad Awada, Dominik Rüttinger, Norbert Marschner and Guy Jérusalem and has published in prestigious journals such as Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

L. Dirix

15 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Dirix Belgium 9 357 120 93 86 74 15 483
Raquel Bratos Spain 8 327 0.9× 116 1.0× 53 0.6× 110 1.3× 83 1.1× 13 609
Chimera R. Peet United States 5 268 0.8× 211 1.8× 108 1.2× 127 1.5× 76 1.0× 5 510
Daisuke Ishida Japan 10 111 0.3× 154 1.3× 24 0.3× 90 1.0× 30 0.4× 22 440
P.G. Jayaprakash India 13 130 0.4× 170 1.4× 87 0.9× 97 1.1× 70 0.9× 22 459
Annegé Vledder Netherlands 4 404 1.1× 139 1.2× 32 0.3× 126 1.5× 103 1.4× 9 626
J.M. del Campo Spain 10 373 1.0× 211 1.8× 82 0.9× 217 2.5× 72 1.0× 17 639
Brigida Anna Maiorano Italy 15 343 1.0× 125 1.0× 24 0.3× 125 1.5× 67 0.9× 58 531
Willa Shi Canada 7 238 0.7× 200 1.7× 41 0.4× 113 1.3× 150 2.0× 7 563
T Kita Japan 5 179 0.5× 310 2.6× 22 0.2× 99 1.2× 107 1.4× 14 871
GG Kenter Netherlands 7 103 0.3× 123 1.0× 53 0.6× 26 0.3× 64 0.9× 8 389

Countries citing papers authored by L. Dirix

Since Specialization
Citations

This map shows the geographic impact of L. Dirix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Dirix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Dirix more than expected).

Fields of papers citing papers by L. Dirix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Dirix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Dirix. The network helps show where L. Dirix may publish in the future.

Co-authorship network of co-authors of L. Dirix

This figure shows the co-authorship network connecting the top 25 collaborators of L. Dirix. A scholar is included among the top collaborators of L. Dirix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Dirix. L. Dirix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Rolfo, Christian, Judith de Vos‐Geelen, Nicolás Isambert, et al.. (2017). PHARMACOKINETICS AND SAFETY OF OLAPARIB IN PATIENTS WITH ADVANCED SOLID TUMORS AND HEPATIC OR RENAL IMPAIRMENT. Clinical Pharmacology & Therapeutics. 101. 1 indexed citations
3.
Lear, John T., Ralf Gutzmer, Michael R. Migden, et al.. (2016). Investigator-assessed efficacy and safety of sonidegib in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma: results of the BOLT 30-month analysis. Melanoma Research. 1 indexed citations
4.
Dirix, L., István Takács, Petros Nikolinakos, et al.. (2016). Abstract S1-04: Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: A phase Ib JAVELIN solid tumor trial. Cancer Research. 76(4_Supplement). S1–4. 89 indexed citations
5.
Laere, Bram De, Dieter Peeters, Roberto Salgado, et al.. (2015). Exploring the intra-patient PIK3CA mutational heterogeneity of circulating tumour cells by massive parallel sequencing in patients with metastatic hormone receptor-positive breast cancer. Annals of Oncology. 26. iii15–iii15. 1 indexed citations
6.
7.
Schmidt, Marcus, M. E. Scheulen, Christian Dittrich, et al.. (2009). An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer. Annals of Oncology. 21(2). 275–282. 108 indexed citations
8.
Burstein, HJ, et al.. (2009). Neratinib (HKI-272), an irreversible pan erbB receptor tyrosine kinase inhibitor: phase 2 results in patients with advanced HER2+ breast cancer.. Cancer Research. 69(2_Supplement). 37–37. 37 indexed citations
9.
Deckers, F., Steven Van Laere, Anthony J. Sprangers, et al.. (2008). IMRT for Rectal Cancer Patients Based on Diffusion Weighted MRI (DWMRI). International Journal of Radiation Oncology*Biology*Physics. 72(1). S251–S251. 5 indexed citations
10.
Wildiers, Hans, et al.. (2008). Consensus text on the utilization of dexrazonane (Savene®) in anthracycline extravasation. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 2(2). 1 indexed citations
11.
Dirix, L., Ilse Van der Auwera, Gert Van den Eynden, et al.. (2006). Real-time RT-PCR of CD146 and VE-cadherin mRNA to detect circulating endothelial cells in peripheral blood of patients with breast cancer. European Journal of Cancer Supplements. 4(2). 144–144. 8 indexed citations
12.
Dam, Peter A. van, et al.. (2003). Intraoperative sentinel node identification with Technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: A feasibility study. International Journal of Gynecological Cancer. 13(2). 182–186. 66 indexed citations
13.
Cutsem, Eric Van, David Cunningham, W.W. ten Bokkel Huinink, et al.. (1999). Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). European Journal of Cancer. 35(1). 54–59. 98 indexed citations
14.
Parizel, Paul M., L. Dirix, D. Van den Weyngaert, et al.. (1996). Deep cerebral invasion by basal cell carcinoma of the scalp. Neuroradiology. 38(6). 575–577. 10 indexed citations
15.
Dirix, L. & van Oosterom At. (1989). The role of ifosfamide in the treatment of sarcomas.. PubMed. 16(1 Suppl 3). 39–45. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raquel Bratos Breakdown of academic impact, for papers by Chimera R. Peet Breakdown of academic impact, for papers by Daisuke Ishida Breakdown of academic impact, for papers by P.G. Jayaprakash Breakdown of academic impact, for papers by Annegé Vledder Breakdown of academic impact, for papers by J.M. del Campo Breakdown of academic impact, for papers by Brigida Anna Maiorano Breakdown of academic impact, for papers by Willa Shi Breakdown of academic impact, for papers by T Kita Breakdown of academic impact, for papers by GG Kenter
Rankless by CCL
2026